Transforming Detection. Improving Lives.TM
Creating a world where oral cancer doesn’t stand a fighting chance.TM
Vigilant BiosciencesⓇ is leading the charge in developing cutting-edge solutions that accelerate oral cancer detection. Our point-of-care solution is simple, accurate*, and cost-effective. We empower clinicians working to improve patient outcomes through earlier intervention.
The innovative BeVigilantTM OraFusion System employs patented technology that detects specific protein markers clinically shown to be associated with early-stage oral cancers. Learn more about our technology:
Standing together to transform the early detection of oral cancer.
To save lives by providing world-class early-detection solutions for cancer.
Our first early cancer detection product:
The BeVigilantTM OraFusion System aids clinicians with identifying patients at risk for oral cancer.
With deep-seated clinical expertise and decades of leadership experience in healthcare diagnostics and the oncology space, the Vigilant Biosciences® leadership team is committed to transforming early oral cancer detection and improving patient outcomes.
*Clinical Data on File